These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 23318052)

  • 21. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
    Sanković-Babić S; Sofronić-Milosavljević Lj
    Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of a disintegrin and metalloproteinase 33 protein in nasal polyposis: an immunohistochemical study.
    Erbek SS; Erinanc H; Erbek S; Topal O; Kiyici H
    Am J Rhinol Allergy; 2010; 24(3):79-82. PubMed ID: 20537279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteoclast stimulating and differentiating factors in human cholesteatoma.
    Hamzei M; Ventriglia G; Hagnia M; Antonopolous A; Bernal-Sprekelsen M; Dazert S; Hildmann H; Sudhoff H
    Laryngoscope; 2003 Mar; 113(3):436-42. PubMed ID: 12616193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Detection of the activity of MMP2 and MMP9 in middle ear cholesteatoma].
    Wang H; Xu Z; Tang A; Su J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Oct; 18(10):620-2. PubMed ID: 15620146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression and significance of TERT and c-Myc oncogene protein product on cholesteatoma epithelium].
    Zhang F; Liu J; Yuan T; Liu Q; Han Z; Wang S; Zhang C; Chen S
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(7):302-4. PubMed ID: 16001896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative analysis of the proliferative capacity of cholesteatomas].
    Bernal Sprekelsen M; Ebmeyer J; Buchbinder A; Sudhoff H
    Acta Otorrinolaringol Esp; 2000 May; 51(4):299-307. PubMed ID: 10984952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium.
    Chae SW; Song JJ; Suh HK; Jung HH; Lim HH; Hwang SJ
    Laryngoscope; 2000 Nov; 110(11):1898-901. PubMed ID: 11081606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural changes and protein expression in the mastoid bone adjacent to cholesteatoma.
    Cinamon U; Kronenberg J; Benayahu D
    Laryngoscope; 2000 Jul; 110(7):1198-203. PubMed ID: 10892696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the p53 and nm23 genes in cholesteatoma.
    Bayazit YA; Bakir K; Kanlikama M; Ozer E; Mumbuc S; Disikirik I; Ucak R
    Acta Otolaryngol; 2002 Oct; 122(7):726-9. PubMed ID: 12484649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of p63 and survivin in cholesteatomas.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim HJ
    Acta Otolaryngol; 2009 Mar; 129(3):268-72. PubMed ID: 18615329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of RANKL and OPG in middle ear cholesteatoma tissue.
    Jeong JH; Park CW; Tae K; Lee SH; Shin DH; Kim KR; Park YW
    Laryngoscope; 2006 Jul; 116(7):1180-4. PubMed ID: 16826057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between human beta defensin expression and cholesteatoma formation.
    Meyer JE; Schwaab M; Beier UH; Görögh T; Buchelt T; Frese K; Maune S
    Auris Nasus Larynx; 2006 Jun; 33(2):159-65. PubMed ID: 16431059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The expressions and correlations of RAR-beta receptors and galectin-8 in human middle ear cholesteatoma].
    Peng L; Cui Y; Liu A
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jul; 18(7):427-9. PubMed ID: 15499989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleoplasm staining patterns and cell cycle-associated expression of Ki-67 in middle ear cholesteatoma.
    Raynov AM; Moon SK; Choung YH; Hong SP; Park K
    Am J Otolaryngol; 2005; 26(5):296-301. PubMed ID: 16137526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1.
    Mallet Y; Nouwen J; Lecomte-Houcke M; Desaulty A
    Laryngoscope; 2003 Feb; 113(2):328-31. PubMed ID: 12567091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of a cathelicidin antimicrobial peptide is augmented in cholesteatoma.
    Jung HH; Chae SW; Jung SK; Kim ST; Lee HM; Hwang SJ
    Laryngoscope; 2003 Mar; 113(3):432-5. PubMed ID: 12616192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin.
    Sudhoff H; Bujía J; Fisseler-Eckhoff A; Holly A; Schulz-Flake C; Hildmann H
    Laryngoscope; 1995 Nov; 105(11):1227-31. PubMed ID: 7475881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of a disintegrin and metalloproteinase-33 protein in vocal fold polyps.
    Akdogan MV; Erinanc H; Topal O; Erbek SS
    J Laryngol Otol; 2015 Jul; 129(7):688-92. PubMed ID: 26153837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of Ki-67 expression in recurrent cases of cholesteatoma].
    Sanli A; Tezer I; Paksoy M; Aydin S; Hardal U; Ozdemir NB
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(2):65-9. PubMed ID: 17527055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential gene expression in cholesteatoma by DNA chip analysis.
    Macias JD; Gerkin RD; Locke D; Macias MP
    Laryngoscope; 2013 Oct; 123 Suppl S5():S1-21. PubMed ID: 23670528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.